Immune Response in Hyperprolactinemia Induced by Sulpiride
スポンサーリンク
概要
- 論文の詳細を見る
Prolactin (PRL) significantly influences cellular and humoral immunity in animals but there is little information on its role in humans. The aim of this study was to investigate effects on immune system due to the pharmacological modification of PRL levels in 5 healthy individuals. The PRL levels were increased 5-fold (p<0.001) by the administration of sulpiride (150 mg per day orally) which causes hyperprolactinemia. Peripheral blood lymphocyte proliferative response to concanavaline-A, CD4 and CD8 subsets, interleukin-2 (IL-2) production, soluble IL-2 receptor expression and serum cortisol were measured at the duration of euprolactinemia and sulpiride-induced hyperprolactinemia. Significant decreases were observed for IL-2 production (p<0.006) and soluble IL-2 receptor expression (p<0.05) under hyperprolactinemia. Con-A stimulated lymphocyte proliferation, CD4 and CD8 subsets were not different. Sulpiride significantly induced hyperproalctinemia and changed the immune system. Our findings suggest that drug-induced hyperprolactinemia plays a critical role in the regulation of the immune response in man.
- 北里大学の論文
- 1999-08-31
著者
-
Kimura Toshimi
Department Of Pathology Kitasato University School Of Medicine
-
Furudate Sen-ichi
Department Of Laboratory Animal Science Kitasato University School Of Medicine
-
Shimada Shigehiko
Department Of Pharmacy Kitasato University Hospital
-
Shimada Shigehiko
Department Of Hospital Pharmacy Kitasato University Hospital
-
Kuroyama Seiichi
Department of Pharmacy, Kitasato University East Hospital
-
Kuroyama Seiichi
Department Of Pharmacy Kitasato University East Hospital
関連論文
- Benzyl Derivatives of N-2,4-Dinitrophenyl-D-glucosamine and Their Use for Oligosaccharide Synthesis
- Trends in the prescriptions of Kampo medicines over a six-year period
- A simple method for peptide purification as a basis for peptidome analysis
- Comparison of Pharmacokinetics of Individual Teicoplanin Components in Patients(Biopharmacy)
- Rescue from Dwarfism by Thyroid Function Compensation in rdw Rats
- Pharmacoepidemiological study of the clinical efficacy of Sho-saiko-to (Xiao-Chai-Hu-Tang) in chronic liver disease patients
- Hemodializability of Pimobendan and Its Active Metabolite, UD-CG 212, in Patients with Congestive Heart Failure Undergoing Hemodialysis
- Improved Quantitative Determination of Total and Unbound Concentrations of Six Teicoplanin Components in Human Plasma by High Performance Liquid Chromatography(Miscellaneous)
- Pituitary GH and Prolactin Deficiency and Testis Enlargement in Hypothyroid Rats caused by Goitrogen Methimazole
- Immune Response in Hyperprolactinemia Induced by Sulpiride
- 2P444 Disease Peptidomics(48. Bioinformatics, genomics and proteomics (II),Poster Session,Abstract,Meeting Program of EABS & BSJ 2006)
- Prolactin Levels and Maternal Behavior Induced by Ultrasonic Vocalizations of the Rat Pup
- Hyperglycemia-induced Alteration in Proteomes of the Rat Renal Cortex
- Serum Itraconazole and Hydroxyitraconazole Concentrations and Interaction with Digoxin in a Case of Chronic Hypertrophic Pachymenigitis Caused by Aspergillus flavus
- Delayed Persistent Estrus Induced by Continuous Lighting after Inadequate Acclimation in Rats
- Genetic Studies on the Pregnancy Block Caused by Pheromones in Mice
- CHARACTERIZATION AND IDENTIFICATION OF PROTEINS RELATED TO THE RDW RAT WITH HEREDITARY DWARFISM
- Developmental delay and unstable state of the testes in the rdw rat with congenital hypothyroidism
- ^I Uptake Competing with iodine Absorption by the Thyroid Gland following Povidone-lodine Skin Application
- .ALPHA.-D-glucosylation by 6-O-acetyl-2,3,4-tri-O-benzyl-D-glucopyranose using trimethylsilyl triflate and pyridine. Synthesis of .ALPHA.-maltosyl and .ALPHA.-isomaltosyl .ALPHA.-D-glucosides.
- Clinical efficacy and safety of arbekacin sulfate in patients with MRSA sepsis or pneumonia : a multi-institutional study
- Practice guidelines for therapeutic drug monitoring of voriconazole : a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring